Hector Chinoy

A Phase 3 Trial of Brepocitinib in Dermatomyositis

International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening: an International Myositis Assessment and Clinical Studies Group (IMACS) initiative

Stratification of biological therapies by pathobiology in biologic-naive patients with rheumatoid arthritis (STRAP and STRAP-EU): two parallel, open-label, biopsy-driven, randomised trials

Comparison of clinical features between patients with anti-synthetase syndrome and dermatomyositis: results from the MYONET registry

Distinct HLA associations with autoantibody-defined subgroups in idiopathic inflammatory myopathies

Healthcare utilization and unmet needs of patients with antisynthetase syndrome: An international patient survey

Higher risk of short term COVID-19 vaccine adverse events in myositis patients with autoimmune comorbidities: results from the COVAD study.

British Society for Rheumatology guideline on management of paediatric, adolescent and adult patients with idiopathic inflammatory myopathy

<scp>COVID</scp>‐19 Vaccination in Autoimmune Diseases (<scp>COVAD</scp>) study: Vaccine safety in idiopathic inflammatory myopathies

COVAD survey 2 long-term outcomes: unmet need and protocol

COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study

COVID-19 vaccination in autoimmune disease (COVAD) survey protocol

Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial

Focused HLA analysis in Caucasians with myositis identifies significant associations with autoantibody subgroups

Genomewide Association Study of Statin‐Induced Myopathy in Patients Recruited Using the <scp>UK</scp> Clinical Practice Research Datalink

Pharmacogenomics of statin-related myopathy: Meta-analysis of rare variants from whole-exome sequencing

2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups

2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups

The EuroMyositis registry: an international collaborative tool to facilitate myositis research

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report

2016 American College of Rheumatology/European League Against Rheumatism criteria for minimal, moderate, and major clinical response in adult dermatomyositis and polymyositis

Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis

2016 American College of Rheumatology/European League Against Rheumatism Criteria for Minimal, Moderate, and Major Clinical Response in Adult Dermatomyositis and Polymyositis: An International Myositis Assessment and Clinical Studies Group/Paediatric Rheumatology International Trials Organisation Collaborative Initiative

Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum

Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups

Efficacy of Subcutaneous Secukinumab in Patients with Active Psoriatic Arthritis Stratified by Prior Tumor Necrosis Factor Inhibitor Use: Results from the Randomized Placebo-controlled FUTURE 2 Study

Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases

Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes

Phenotype Standardization for Statin-Induced Myotoxicity